We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The agenda and papers available for the Public Health England (PHE) Board meeting of 23 May 2018.
Percentage of invoices to Public Health England paid within 5, 10 and 30 working days of receipt, from April 2017 onward.
The agenda and papers available for the Public Health England (PHE) Board meeting of 21 March 2018.
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between April and June 2017 (quarter 1).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2017 (quarter 2).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2016 (quarter 3).
The agenda and papers available for the Public Health England (PHE) Board meeting of 14 February 2018.
This document defines how DHSC and PHE will work to serve the public and the taxpayer, and how they discharge their accountability responsibilities.
Details of PHE's government procurement card expenditure over £500.
Details of Public Health England transactions over £25,000 in October 2017.
The agenda and papers available for the Public Health England (PHE) Board meeting of 29 November 2017.
Details of Public Health England transactions over £25,000 in August 2017.
Details of Public Health England transactions over £25,000 in September 2017.
Advisory Board on the Registration of Homeopathic Products and Herbal Medicines Advisory Committee Annual Reports 2016, along with a record of members' interests in the pharmaceutical industry.
This report summarises the work of the UK National Screening Committee (UK NSC) to review screening recommendations from 1 April 2016 to 31 March 2017.
Details of Public Health England transactions over £25,000 in May 2017.
Details of Public Health England transactions over £25,000 in April 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).